{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:34:07Z","timestamp":1761514447405,"version":"3.37.3"},"reference-count":58,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1D1A3B03028559"],"award-info":[{"award-number":["2017R1D1A3B03028559"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1A3B03028559"],"award-info":[{"award-number":["2017R1D1A3B03028559"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2019,12,30]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Chalcones are considered as the selective scaffold for the inhibition of MAO-B.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>A previously synthesized ethyl acetohydroxamate-chalcones (L1-L22) were studied for their inhibitory activities against human recombinant monoamine oxidase A and B (hMAO-A and hMAO-B, respectively) and acetylcholinesterase (AChE) as multi-target directed ligands for the treatment of Alzheimer\u2019s Disease (AD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Enzyme inhibition studies of MAO-A, MAO-B and AChE is carried out. Computational studies such as Molecular docking, Molecular Mechanics\/Generalized Born Surface Area calculations, ADMET prediction, and protein target prediction are also performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Among the screened compounds, compound L3 has most potent hMAO-B inhibition with an IC50 value of 0.028 \u00b1 0.0016 \u00b5M, and other compounds, L1, L2, L4, L8, L12, and L21 showed significant potent hMAO-B inhibition with IC50 values of 0.051 \u00b1 0.0014, 0.086 \u00b1 0.0035, 0.036 \u00b1 0.0011, 0.096 \u00b1 0.0061, 0.083 \u00b1 0.0016, and 0.038 \u00b1 0.0021 \u00b5M, respectively. On the other hand, among the tested compounds, compound L13 showed highest hMAO-A inhibition with an IC50 value of 0.51\u00b1 0.051 \u00b5M and L9 has a significant value of 1.85 \u00b1 0.045 \u00b5M. However, the compounds L3 and L4 only showed high selectivities for hMAO-B with Selectivity Index (SI) values of 621.4 and 416.7, respectively. Among the substituents in ring A of ethyl acetohydroxamate-chalcones (L1-L9), F atom at p-position (L3) showed highest inhibitory effect against hMAO-B. This result supports the uniqness and bizarre behavior of fluorine. Moreover, chalcones L3, L4, L9, L11, and L12 showed potential AChE inhibitory effect with IC50 values of 0.67, 0.85, 0.39, 0.30, and 0.45 \u00b5M, respectively. Inhibitions of hMAO-B by L3 or L4 were recovered to the level of the reversible reference (lazabemide), and were competitive with Ki values of 0.0030 \u00b1 0.0002 and 0.0046 \u00b1 0.0005 \u00b5M, respectively. Inhibitions of AChE by L3 and L11 were of the competitive and mixed types with Ki values of 0.30 \u00b1 0.044 and 0.14 \u00b1 0.0054 \u00b5M, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The studies indicated that L3 and L4 are considered to be promising multitarget drug molecules with potent, selective, and reversible competitive inhibitors of hMAO-B and with highly potent AChE inhibitory effect.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871527318666190906101326","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T05:20:57Z","timestamp":1567833657000},"page":"643-654","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer\u2019s Disease"],"prefix":"10.2174","volume":"18","author":[{"family":"Reeta","sequence":"first","affiliation":[{"name":"Centre for Fire, Explosive and Environment Saftey, DRDO, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Cheol","family":"Baek","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Pil","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"Rangarajan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Sri Venketeswara College, University of Delhi, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ayushee","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Delhi, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi Pal","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Sri Venketeswara College, University of Delhi, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjula","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shivaji College, University of Delhi, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Felice","family":"Mangiatordi","sequence":"additional","affiliation":[{"name":"Istituto di Cristallografia, Consiglio Nazionale delle Ricerche, Via G. Amendola 122\/O, 70126 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orazio","family":"Nicolotti","sequence":"additional","affiliation":[{"name":"Dipartimento di Farmacia\u2014 Scienze del Farmaco, Universit\u00e1 degli Studi di Bari \u201cAldo Moro\u201d, via E. Orabona, 4, I-70125 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[{"name":"Division of Drug Design and Medicinal Chemistry Research Lab, Department of Pharmaceutical Chemistry, Ahalia School of Pharmacy, Palakkad-678557, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2174\/1871527317666180724150839","author":"Jiang X.W.","year":"2018","unstructured":"Jiang X.W.; Lu H.Y.; Xu Z.; In Silico analyses for key genes and molecular genetic mechanism in epilepsy and Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 2018,608-617","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/1871527317666180627122448","volume":"17","author":"Singh A.","year":"2018","unstructured":"Singh A.; Hasan A.; Tiwari S.; Pandey L.M.; Therapeutic advancement in Alzheimer disease, new hopes on the horizon? CNS Neurol Disord Drug Targets 2018,17(8),571-589","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1871527317666180213143832","volume":"17","author":"Neelakandan A.R.","year":"2018","unstructured":"Neelakandan A.R.; Rajanikant G.K.; Commentary endophenotypes as disease modifiers: Decoding the biology of Alzheimer\u2019s by genome-wide association studies. CNS Neurol Disord Drug Targets 2018,17(1),6-8","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2012.10.558","volume":"62","author":"Ayton S.","year":"2013","unstructured":"Ayton S.; Lei P.; Bush A.I.; Metallostasis in Alzheimer\u2019s disease. Free Radic Biol Med 2013,62,76-89","journal-title":"Free Radic Biol Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/1871527317666180508123050","volume":"17","author":"Beg T.","year":"2018","unstructured":"Beg T.; Jyoti S.; Naz F.; Protective effect of kaempferol on the transgenic drosophila model of Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 2018,17(6),421-429","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","volume":"18","author":"Medina-Franco J.L.","year":"2013","unstructured":"Medina-Franco J.L.; Giulianotti M.A.; Welmaker G.S.; Houghten R.A.; Shifting from the single to the multitarget paradigm in drug discovery. Drug Discov Today 2013,18(9-10),495-501","journal-title":"Drug Discov Today"},{"key":"ref=7","first-page":"93","author":"Catto M.","year":"2019","unstructured":"Catto M.; Trisciuzzi D.; Alberga D.; Mangiatordi G.F.; Nicolotti O.; Multitarget drug design for neurodegenerative diseases 2019,93-105","journal-title":"Multitarget drug design for neurodegenerative diseases"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm7009364","volume":"51","author":"Cavalli A.","year":"2008","unstructured":"Cavalli A.; Bolognesi M.L.; Minarini A.; Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008,51(3),347-372","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.4155\/fmc-2017-0036","volume":"9","author":"Knez D.","year":"2017","unstructured":"Knez D.; Sova M.; Ko\u0161ak U.; Gobec S.; Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer\u2019s disease. Future Med Chem 2017,9(8),811-832","journal-title":"Future Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ejps.2017.08.004","volume":"109","author":"Pisani L.","year":"2017","unstructured":"Pisani L.; De Palma A.; Giangregorio N.; Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl)hydrazine, a water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity. Eur J Pharm Sci 2017,109,381-388","journal-title":"Eur J Pharm Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1021\/acs.jmedchem.6b00562","volume":"59","author":"Pisani L.","year":"2016","unstructured":"Pisani L.; Farina R.; Catto M.; Exploring basic tail modifications of coumarin-based dual acetylcholinesterase-monoamine oxidase b inhibitors. Identification of water-soluble, brain-permeant neuroprotective multitarget agents. J Med Chem 2016,59(14),6791-6806","journal-title":"J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/molecules21030362","volume":"21","author":"Pisani L.","year":"2016","unstructured":"Pisani L.; Farina R.; Soto-Otero R.; Searching for multi-targeting neurotherapeutics against Alzheimer\u2019s discovery of potent ache-MAO B inhibitors through the decoration of the 2H-Chromen-2-one structural motif. Molecules 2016,21(3),362","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1021\/acs.jmedchem.5b00599","volume":"58","author":"Farina R.","year":"2015","unstructured":"Farina R.; Pisani L.; Catto M.; Structure-based design and optimization of multitarget-directed 2 H-chromen-2-one derivatives as potent inhibitors of monoamine oxidase b and cholinesterases. J Med Chem 2015,58(14),5561-5578","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1573408012666160402001715","volume":"12","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Mathew G.E.; Suresh J.; Monoamine oxidase inhibitors, perspective design for the treatment of depression and neurological disorders. Curr Enzym Inhib 2016,12,115-122","journal-title":"Curr Enzym Inhib"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/1871527316666170124165222","volume":"16","author":"Dezsi L.","year":"2017","unstructured":"Dezsi L.; Vecsei L.; Monoamine oxidase B inhibitors in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 2017,16(4),425-439","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bioorg.2018.06.009","volume":"80","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Rakesh K.P.; Bukhari S.N.A.; Balakrishna M.; Manukumar H.M.; Qin H.L.; Multi-targetable chalcone analogs to treat deadly Alzheimer\u2019s disease, current view and upcoming advice. Bioorg Chem 2018,80,86-93","journal-title":"Bioorg Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.2174\/092986711797379302","volume":"18","author":"Pisani L.","year":"2011","unstructured":"Pisani L.; Catto M.; Leonetti F.; Targeting monoamine oxidases with multipotent ligands, an emerging strategy in the search of new drugs against neurodegenerative diseases. Curr Med Chem 2011,18(30),4568-4587","journal-title":"Curr Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bionut.2014.04.003","volume":"4","author":"Mathew B.","year":"2014","unstructured":"Mathew B.; Suresh J.; Anbazhagan S.; Paulraj J.; Krishnan G.K.; Heteroaryl chalcones mini-review about their therapeutic voyage. Biomed Prev Nut 2014,4,451-458","journal-title":"Biomed Prev Nut"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ejmech.2015.01.051","volume":"92","author":"Mahapatra D.K.","year":"2015","unstructured":"Mahapatra D.K.; Asati V.; Bharti S.K.; Chalcones and their therapeutic targets for the management of diabetes, structural and pharmacological perspectives. Eur J Med Chem 2015,92,839-865","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1570193X11310010006","volume":"10","author":"Bhukari S.N.A.","year":"2013","unstructured":"Bhukari S.N.A.; Jasamai M.; Jantan I.; Ahmad W.; Review of methods and various catalysts used for chalcone synthesis. Mini Rev Org Chem 2013,10,73-83","journal-title":"Mini Rev Org Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1016\/j.bmc.2014.08.033","volume":"22","author":"Liu H.R.","year":"2014","unstructured":"Liu H.R.; Liu X.J.; Fan H.Q.; Tang J.J.; Gao X.H.; Liu W.K.; Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem 2014,22(21),6124-6133","journal-title":"Bioorg Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1016\/j.bmcl.2013.06.050","volume":"23","author":"Robinson S.J.","year":"2013","unstructured":"Robinson S.J.; Petzer J.P.; Petzer A.; Bergh J.J.; Lourens A.C.U.; Selected furanochalcones as inhibitors of monoamine oxidase. Bioorg Med Chem Lett 2013,23(17),4985-4989","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1016\/j.bmcl.2015.09.049","volume":"25","author":"Minders C.","year":"2015","unstructured":"Minders C.; Petzer J.P.; Petzer A.; Lourens A.C.U.; Monoamine oxidase inhibitory activities of heterocyclic chalcones. Bioorg Med Chem Lett 2015,25(22),5270-5276","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1002\/slct.201702141","volume":"2","author":"Mathew B.","year":"2017","unstructured":"Mathew B.; Ucar G.; Raphael C.; Mathew G.E.; Joy M.; Machaba K.E.; Characterization of thienylchalcones as hMAO-B inhibitors: Synthesis, biochemistry and molecular dynamics studies. ChemistrySelect 2017,2,11113-11119","journal-title":"ChemistrySelect"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejmech.2016.02.038","volume":"114","author":"Hammuda A.","year":"2016","unstructured":"Hammuda A.; Shalaby R.; Rovida S.; Edmondson D.E.; Binda C.; Khalil A.; Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors. Eur J Med Chem 2016,114,162-169","journal-title":"Eur J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2174\/1573406410666141229101130","volume":"11","author":"Zaib S.","year":"2015","unstructured":"Zaib S.; Farooq Rizvi S.U.; Aslam S.; Ahmad M.; Al-Rashida M.; Iqbal J.; Monoamine oxidase inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones. Med Chem 2015,11(5),497-505","journal-title":"Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1871524915666151002124443","volume":"16","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Haridas A.; Suresh J.; Mathew G.E.; U\u00e7ar G.; Jayaprakash V.; Monoamine oxidase inhibitory actions of chalcones. A mini review. Cent Nerv Syst Agents Med Chem 2016,16(2),120-136","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1871524919666190131160122","volume":"19","author":"Mathew B.","year":"2019","unstructured":"Mathew B.; Unraveling the structural requirements of chalcone chemistry towards monoamine oxidase inhibition. Cent Nerv Syst Agents Med Chem 2019,19(1),6-7","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijbiomac.2017.11.159","volume":"108","author":"Suresh J.","year":"2018","unstructured":"Suresh J.; Baek S.C.; Ramakrishnan S.P.; Kim H.; Mathew B.; Discovery of potent and reversible MAO-B inhibitors as furanochalcones. Int J Biol Macromol 2018,108,660-664","journal-title":"Int J Biol Macromol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"(Pt A): 1321-9","DOI":"10.1016\/j.ijbiomac.2017.05.162","volume":"104","author":"Mathew B","year":"2017","unstructured":"Mathew B; Mathew GE; Ucar G; Monoamine oxidase inhibitory activity of methoxy-substituted chalcones. Int J Biol Macromol 2017,104,(Pt A): 1321-9","journal-title":"Int J Biol Macromol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopha.2018.06.064","volume":"106","author":"Sasidharan R.","year":"2018","unstructured":"Sasidharan R.; Baek S.C.; Sreedharannair L.M.; Kim H.; Mathew B.; Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors. Biomed Pharmacother 2018,106,8-13","journal-title":"Biomed Pharmacother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/jm801590u","volume":"52","author":"Chimenti F.","year":"2009","unstructured":"Chimenti F.; Fioravanti R.; Bolasco A.; Chalcones: A valid scaffold for monoamine oxidases inhibitors. J Med Chem 2009,52(9),2818-2824","journal-title":"J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bioorg.2015.07.001","volume":"62","author":"Mathew B.","year":"2015","unstructured":"Mathew B.; Mathew G.E.; U\u00e7ar G.; Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies. Bioorg Chem 2015,62,22-29","journal-title":"Bioorg Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2174\/1570178612666150903213416","volume":"12","author":"Mathew B.","year":"2015","unstructured":"Mathew B.; U\u00e7ar G.; Yabano\u011flu-\u00c7ift\u00e7i S.; Development of fluorinated thienylchalcones as monoamine oxidase-b inhibitors: Design, synthesis, biological evaluation and molecular docking studies. Lett Org Chem 2015,12,605-613","journal-title":"Lett Org Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/cbdv.201500367","volume":"13","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Mathew G.E.; U\u00e7ar G.; Potent and selective monoamine oxidase-b inhibitory activity: Fluoro- vs. trifluoromethyl-4-hydroxylated chalcone derivatives. Chem Biodivers 2016,13(8),1046-1052","journal-title":"Chem Biodivers"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/cmdc.201600497","volume":"11","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; U\u00e7ar G.; Mathew G.E.; Monoamine oxidase inhibitory activity: Methyl- versus chloro-chalcone derivatives. ChemMedChem 2016,11(24),2649-2655","journal-title":"ChemMedChem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ijbiomac.2016.05.110","volume":"91","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Haridas A.; U\u00e7ar G.; Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors. Int J Biol Macromol 2016,91,680-695","journal-title":"Int J Biol Macromol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/cmdc.201600122","volume":"11","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Haridas A.; U\u00e7ar G.; Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: A new class of reversible MAO-B inhibitors. ChemMedChem 2016,11(11),1161-1171","journal-title":"ChemMedChem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ardp.201600088","volume":"349","author":"Sasidharan R.","year":"2016","unstructured":"Sasidharan R.; Manju S.L.; U\u00e7ar G.; Baysal I.; Mathew B.; Identification of indole based chalcones: Discovery of potent, selective and reversible class of MAO-B inhibitors. Arch Pharm (Weinheim) 2016,349(8),627-637","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1021\/acs.jpcb.6b09451","volume":"121","author":"Mathew B.","year":"2017","unstructured":"Mathew B.; Adeniyi A.A.; Dev S.; Pharmacophore based 3D-QSAR analysis of thienyl chalcone as new class of human MAO-B inhibitors. Investigation of combined quantum chemical and molecular dynamics approach. J Phys Chem B 2017,121(6),1186-1203","journal-title":"J Phys Chem B"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800309","volume":"352","author":"Mathew B.","year":"2019","unstructured":"Mathew B.; Baek S.C.; Thomas Parambi D.G.; Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole. Arch Pharm (Weinheim) 2019,352(4)","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1002\/slct.201901093","volume":"4","author":"Lakshminarayan B.","year":"2019","unstructured":"Lakshminarayan B.; Baek S.C.; Kannappan N.; Ethoxylated head of chalcones as a new class of multi-targeted MAO inhibitors. ChemistrySelect 2019,4(21),6614-6619","journal-title":"ChemistrySelect"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bioorg.2019.02.016","volume":"86","author":"Reeta V.R.","year":"2019","unstructured":"Reeta V.R.; Rangarajan T.M.; Ayushee, Singh RP, Singh M. Synthesis of novel chalcones through palladium-catalyzed C-O cross coupling reaction of bromochalcones with ethyl acetohydroxamate and their anti-plasmodial evaluation against plasmodium falcipuram in vitro. Bioorg Chem 2019,86,631-640","journal-title":"Bioorg Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1039\/C8MD00399H","volume":"9","author":"Mathew B.","year":"2018","unstructured":"Mathew B.; Baek S.C.; Grace T.P.D.; Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors. MedChemComm 2018,9(11),1871-1881","journal-title":"MedChemComm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1016\/j.bmcl.2016.08.044","volume":"26","author":"Lee H.W.","year":"2016","unstructured":"Lee H.W.; Ryu H.W.; Kang M.G.; Park D.; Oh S.R.; Kim H.; Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg Med Chem Lett 2016,26(19),4714-4719","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bmcl.2018.01.049","volume":"28","author":"Baek S.C.","year":"2018","unstructured":"Baek S.C.; Lee H.W.; Ryu H.W.; Selective inhibition of monoamine oxidase A by hispidol. Bioorg Med Chem Lett 2018,28(4),584-588","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"Ellman G.L.","year":"1961","unstructured":"Ellman G.L.; Courtney K.D.; Andres V.; Feather-Stone R.M.; A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961,7,88-95","journal-title":"Biochem Pharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bioorg.2018.10.051","volume":"83","author":"Baek S.C.","year":"2019","unstructured":"Baek S.C.; Park M.H.; Ryu H.W.; Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A. Bioorg Chem 2019,83,317-325","journal-title":"Bioorg Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1073\/pnas.0710626105","volume":"105","author":"Son S.Y.","year":"2008","unstructured":"Son S.Y.; Ma J.; Kondou Y.; Yoshimura M.; Yamashita E.; Tsukihara T.; Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates\/inhibitors. Proc Natl Acad Sci USA 2008,105(15),5739-5744","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"Binda C.","year":"2007","unstructured":"Binda C.; Wang J.; Pisani L.; Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs. J Med Chem 2007,50(23),5848-5852","journal-title":"J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"Cheung J.","year":"2012","unstructured":"Cheung J.; Rudolph M.J.; Burshteyn F.; Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 2012,55(22),10282-10286","journal-title":"J Med Chem"},{"key":"ref=52","volume":"93","author":"Parambi D.G.T.","year":"2019","unstructured":"Parambi D.G.T.; Oh J.M.; Baek S.C.; Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. Bioorg Chem 2019,93","journal-title":"Bioorg Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"Genheden S.","year":"2015","unstructured":"Genheden S.; Ryde U.; The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 2015,10(5),449-461","journal-title":"Expert Opin Drug Discov"},{"key":"ref=54","unstructured":"Announcing Schr\u00f6dinger Software Release 2019-1. Available form: ,B6dinger-software-release-2019-1","first-page":"B6dinger-software-release-2019-1"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/molecules24122233","volume":"24","author":"Montaruli M.","year":"2019","unstructured":"Montaruli M.; Alberga D.; Ciriaco F.; Accelerating drug discovery by early protein drug target prediction based on multi-fingerprint similarity search. Molecules 2019,24(12),2233","journal-title":"Molecules"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1021\/ci700119r","volume":"47","author":"Nicolotti O.","year":"2007","unstructured":"Nicolotti O.; Miscioscia T.F.; Leonetti F.; Muncipinto G.; Carotti A.; Screening of matrix metalloproteinases available from the protein data bank: Insights into biological functions, domain organization, and zinc binding groups. J Chem Inf Model 2007,47(6),2439-2448","journal-title":"J Chem Inf Model"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/acs.jcim.8b00698","volume":"59","author":"Alberga D.","year":"2019","unstructured":"Alberga D.; Trisciuzzi D.; Montaruli M.; Leonetti F.; Mangiatordi G.F.; Nicolotti O.; A new approach for drug target and bioactivity prediction: The Multi-fingerprint Similarity Search aLgorithm (MuSSeL). J Chem Inf Model 2019,59(1),586-596","journal-title":"J Chem Inf Model"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"Gaulton A.","year":"2017","unstructured":"Gaulton A.; Hersey A.; Nowotka M.; The ChEMBL database in 2017. Nucleic Acids Res 2017,45(D1),D945-D954","journal-title":"Nucleic Acids Res"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:53:35Z","timestamp":1611017615000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174727\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,30]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,12,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527318666190906101326","relation":{},"ISSN":["1871-5273"],"issn-type":[{"type":"print","value":"1871-5273"}],"subject":[],"published":{"date-parts":[[2019,12,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}